| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +80.00% | -6.34% | -0.19% | -6.15% | -6.31% | — |
| 14d | 5 | +80.00% | -2.76% | +0.84% | -3.60% | -9.83% | — |
| 30d | 5 | +80.00% | +4.05% | +1.78% | +2.27% | -4.10% | — |
| 60d | 5 | +40.00% | +5.15% | +1.36% | +3.79% | +5.75% | — |
| 90d | 5 | +80.00% | +4.89% | +4.95% | -0.06% | -0.31% | — |
| 180d | 5 | +60.00% | -9.01% | +7.89% | -19.61% | -18.60% | — |
| 1y | 5(3 pending) | +50.00% | -30.41% | +5.18% | -35.59% | -35.59% | — |
| 2y | 5(3 pending) | +50.00% | -20.04% | +3.52% | -33.64% | -33.64% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 93,000 | — | — | 93,000 | Jun 25, 2026 | Jun 29, 2026 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 4,166 | $29.10 | $121.2K | 30,796 | Dec 4, 2025 | Dec 8, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 341 | $23.95 | $8.2K | 35,392 | Aug 13, 2025 | Aug 15, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 430 | $25.42 | $10.9K | 34,962 | Aug 13, 2025 | Aug 15, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jun 5, 2025 | Jun 9, 2025 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 75,000 | — | — | 75,000 | Jun 13, 2024 | Jun 17, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 9,540 | — | — | 18,454 | Jun 5, 2024 | Jun 7, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP & GENERAL COUNSEL | 9,540 | $10.38 | $99.0K | 35,464 | Jun 5, 2024 | Jun 7, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 8,006 | $33.60 | $269.0K | 25,924 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP & GENERAL COUNSEL | 8,006 | $10.38 | $83.1K | 33,930 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 8,006 | — | — | 27,994 | Jun 3, 2024 | Jun 5, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP & GENERAL COUNSEL | 4,166 | $9.02 | $37.6K | 5,924 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 20,000 | — | — | 0 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | SALE SVP & GENERAL COUNSEL | 4,166 | — | — | 0 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP & GENERAL COUNSEL | 20,000 | $2.78 | $55.6K | 25,924 | Feb 13, 2024 | Feb 15, 2024 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 74,000 | — | — | 74,000 | Jun 15, 2023 | Jun 20, 2023 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 73,000 | — | — | 73,000 | Jun 16, 2022 | Jun 17, 2022 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASE SVP & General Counsel | 430 | $46.28 | $19.9K | 430 | Aug 11, 2021 | Aug 13, 2021 ↗ | View → |
| CLDX CELLDEX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 73,000 | — | — | 73,000 | Jun 17, 2021 | Jun 21, 2021 ↗ | View → |